Collaboration to launch for the treatment of type 2 diabetes in China
Two companies will work closely together on future development, distribution, promotion, access, marketing and sales of Invokana (canagliflozin) for type 2 diabetes...
List view / Grid view
News
Developing a new radioactive marker for cancer diagnosis and detection
Scientists are conducting a joint study to develop a radioactive marker, based on nanoparticles, for the detection of cancer...
Mouse model shows success of senolytic drugs in reversing senescent cell damage
An NIH-funded study has demonstrated that a combination of senolytic drugs can successfully reverse cell senescence in mice; providing potential avenue for future age-related treatment study.
Chemspec Europe 2018 in Cologne closes with a record in visitor numbers
The 33rd edition of Chemspec Europe, International Exhibition for Fine and Speciality Chemicals, ended after two successful show days with record visitor numbers...
The future of water is clear – MECO ushers in a more efficient and environmentally friendly future for water purification
Taking advantage of technology developed in recent years, MECO announces smartANALYTICS® as a means of connecting its water purification machines and systems with big data analytics and in house expertise...
Nanofiber-based wound dressings induce production of antimicrobial peptide
Nanofiber-based wound dressings loaded with vitamin D spur the production of an antimicrobial peptide, a key step forward in the battle against surgical site infections...
New anti-clotting drugs linked to lower risk of serious bleeding
Direct oral anticoagulants (DOACs) used to treat serious blood clots are associated with reduced risks of major bleeding compared with the older anti-clotting drug, warfarin, finds a new study.
Plerixafor may protect against smoke-related COPD symptoms
A drug used in stem cell therapy to treat certain cancers may also protect against cigarette smoke-induced lung injury...
Tecan’s Spark® reader aiding research into rare skin disease
Researchers at the University Hospital of Salzburg's EB House Austria are using a Tecan Spark® multimode reader to investigate epidermolysis bullosa (EB), a rare inherited disease that causes the skin to become ‘as fragile as a butterfly’s wings’, blistering in response to friction or trauma...
Flow chemistry helps enhance biocatalysis processes
An Asia flow chemistry system from Syrris is helping to streamline biocatalysis reactions for researchers at the Biocatalysis and Organic Synthesis Group at the Chemistry Institute of the Federal University of Rio de Janeiro...
FDA approves Aristada Inito for the initiation of Aristada for schizophrenia
Novel regimen enables physicians to fully dose up to two months of Aristada treatment on day one...
Researcher uses HPV vaccine to treat patient with skin cancer
Evidence suggests the human papillomavirus plays a role in the development of some types of this skin cancer...
Can aspirin treat Alzheimer’s?
A study shows low-dose aspirin may aid removal of harmful amyloid plaque in the brain...
Metformin reverses established lung fibrosis
A diabetes drug suggests a potential therapy for idiopathic pulmonary fibrosis...
Lunch & Learn event – in association with NIBRT – will introduce the benefits of Quantum peristaltic pump technology for downstream bioprocesses
Bioprocessing professionals in search of a technology that could revolutionise their downstream processing, are invited to attend a Lunch and Learn event from Watson-Marlow Fluid Technology Group (WMTFG), in association with The National Institute for Bioprocessing Research and Training (NIBRT)...
